Skip to main content

Advertisement

Log in

Association Between Chronic Hepatitis C Virus Infection and Bone Mineral Density

  • Original Research
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Abstract

Whether chronic hepatitis C virus (HCV) infection is a risk factor for the development of bone disease has long been controversial. For this reason, chronic HCV-infected participants (n = 69) were recruited into a prospective cohort study and underwent dual-energy X-ray absorptiometry for determination of bone mineral density (BMD). Fibrosis staging was evaluated according to the noninvasive index FIB-4. T scores at the femoral neck and lumbar spine were used as the primary outcome variables to assess the association between degree of liver disease and BMD. The study cohort was 41 % male with a mean age of 53.6 years. The mean BMD, Z score, and T score values of lumbar spine in chronic hepatitis C (CHC) patients were significantly lower than those in healthy controls (p < 0.001). The rate of osteoporosis for CHC patients aged 45–54 years was significantly higher than that of the control group (p = 0.011). Bone alkaline phosphatase and C-terminal cross-linking telopeptide of type I collagen levels were also significantly higher in CHC patients with reduced BMD. Patients with more advanced liver fibrosis had significantly lower BMD. In conclusion, reduced BMD is common in this population of chronic HCV-infected patients and associated with liver disease severity. This extrahepatic manifestation is probably secondary to increased bone turnover in osteodystrophy pathogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Raisz LG (2005) Clinical practice. Screening for osteoporosis. N Engl J Med 353:164–171

    Article  PubMed  CAS  Google Scholar 

  2. Collier J (2007) Bone disorders in chronic liver disease. Hepatology 46:1271–1278

    Article  PubMed  CAS  Google Scholar 

  3. Hay JE, Guichelaar MM (2005) Evaluation and management of osteoporosis in liver disease. Clin Liver Dis 9:747–766

    Article  PubMed  Google Scholar 

  4. Leslie WD, Bernstein CN, Leboff MS (2003) AGA technical review on osteoporosis in hepatic disorders. Gastroenterology 125:941–966

    Article  PubMed  Google Scholar 

  5. Monegal A, Navasa M, Guanabens N, Peris P, Pons F, Martinez de Osaba MJ, Rimola A, Rodes J, Munoz-Gomez J (1997) Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation. Calcif Tissue Int 60:148–154

    Article  PubMed  CAS  Google Scholar 

  6. Crosbie OM, Freaney R, McKenna MJ, Hegarty JE (1999) Bone density, vitamin D status, and disordered bone remodeling in end-stage chronic liver disease. Calcif Tissue Int 64:295–300

    Article  PubMed  CAS  Google Scholar 

  7. Bagur A, Mautalen C, Findor J, Sorda J, Somoza J (1998) Risk factors for the development of vertebral and total skeleton osteoporosis in patients with primary biliary cirrhosis. Calcif Tissue Int 63:385–390

    Article  PubMed  CAS  Google Scholar 

  8. Collier JD, Ninkovic M, Compston JE (2002) Guidelines on the management of osteoporosis associated with chronic liver disease. Gut 50(Suppl 1):i1–i9

    Article  PubMed  Google Scholar 

  9. WHO (1999) Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 6:35–47

    Article  Google Scholar 

  10. Yucel AE, Kart-Koseoglu H, Isiklar I, Kuruinci E, Ozdemir FN, Arslan H (2004) Bone mineral density in patients on maintenance hemodialysis and effect of chronic hepatitis C virus infection. Ren Fail 26:159–164

    Article  PubMed  Google Scholar 

  11. Luchi S, Fiorini I, Meini M, Scasso A (2005) Alterations of bone metabolism in patients with chronic C virus hepatitis [in Italian]. Infez Med 13:23–27

    PubMed  Google Scholar 

  12. Schiefke I, Fach A, Wiedmann M, Aretin AV, Schenker E, Borte G, Wiese M, Moessner J (2005) Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection. World J Gastroenterol 11:1843–1847

    PubMed  CAS  Google Scholar 

  13. Yenice N, Gumrah M, Mehtap O, Kozan A, Turkmen S (2006) Assessment of bone metabolism and mineral density in chronic viral hepatitis. Turk J Gastroenterol 17:260–266

    PubMed  Google Scholar 

  14. Lo Re V 3rd, Guaraldi G, Leonard MB, Localio AR, Lin J, Orlando G, Zirilli L, Rochira V, Kostman JR, Tebas P (2009) Viral hepatitis is associated with reduced bone mineral density in HIV-infected women but not men. AIDS 23:2191–2198

    Article  PubMed  Google Scholar 

  15. Nanda KS, Ryan EJ, Murray BF, Brady JJ, McKenna MJ, Nolan N, O’Farrelly C, Hegarty JE (2009) Effect of chronic hepatitis C virus infection on bone disease in postmenopausal women. Clin Gastroenterol Hepatol 7:894–899

    Article  PubMed  CAS  Google Scholar 

  16. El-Maouche D, Mehta SH, Sutcliffe C, Higgins Y, Torbenson MS, Moore RD, Thomas DL, Sulkowski MS, Brown TT (2011) Controlled HIV viral replication, not liver disease severity associated with low bone mineral density in HIV/HCV co-infection. J Hepatol 55:770–776

    Article  PubMed  Google Scholar 

  17. Wiegard C, Schramm C, Lohse AW (2009) Scoring systems for the diagnosis of autoimmune hepatitis: past, present, and future. Semin Liver Dis 29:254–261

    Article  PubMed  Google Scholar 

  18. Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD (2000) Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. J Bone Miner Res 15:1526–1536

    Article  PubMed  CAS  Google Scholar 

  19. Garnero P, Gineyts E, Riou JP, Delmas PD (1994) Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease. J Clin Endocrinol Metab 79:780–785

    Article  PubMed  CAS  Google Scholar 

  20. Vallet-Pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, Dhalluin-Venier V, Fontaine H, Pol S (2007) FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest. Hepatology 46:32–36

    Article  PubMed  CAS  Google Scholar 

  21. LaForgia J, Dollman J, Dale MJ, Withers RT, Hill AM (2009) Validation of DXA body composition estimates in obese men and women. Obesity (Silver Spring) 17:821–826

    Article  Google Scholar 

  22. Bredella MA, Ghomi RH, Thomas BJ, Torriani M, Brick DJ, Gerweck AV, Misra M, Klibanski A, Miller KK (2010) Comparison of DXA and CT in the assessment of body composition in premenopausal women with obesity and anorexia nervosa. Obesity (Silver Spring) 18:2227–2233

    Article  Google Scholar 

  23. Huang GS, Chu TS, Lou MF, Hwang SL, Yang RS (2009) Factors associated with low bone mass in the hemodialysis patients—a cross-sectional correlation study. BMC Musculoskelet Disord 10:60

    Article  PubMed  Google Scholar 

  24. Mauck KF, Clarke BL (2006) Diagnosis, screening, prevention, and treatment of osteoporosis. Mayo Clin Proc 81:662–672

    Article  PubMed  CAS  Google Scholar 

  25. McCaughan GW, Feller RB (1994) Osteoporosis in chronic liver disease: pathogenesis, risk factors, and management. Dig Dis 12:223–231

    Article  PubMed  CAS  Google Scholar 

  26. Rouillard S, Lane NE (2001) Hepatic osteodystrophy. Hepatology 33:301–307

    Article  PubMed  CAS  Google Scholar 

  27. Hsu SH, Tsai KS (1997) Different age-related trends of bone and nonbone forms of alkaline phosphatase in Chinese men and women. Clin Chem 43:186–188

    PubMed  CAS  Google Scholar 

  28. Iki M, Kajita E, Dohi Y, Nishino H, Kusaka Y, Tsuchida C, Yamamoto K, Ishii Y (1996) Age, menopause, bone turnover markers and lumbar bone loss in healthy Japanese women. Maturitas 25:59–67

    Article  PubMed  CAS  Google Scholar 

  29. Melton LJ 3rd, Khosla S, Atkinson EJ, O’Fallon WM, Riggs BL (1997) Relationship of bone turnover to bone density and fractures. J Bone Miner Res 12:1083–1091

    Article  PubMed  Google Scholar 

  30. Tsai KS, Pan WH, Hsu SH, Cheng WC, Chen CK, Chieng PU, Yang RS, Twu ST (1996) Sexual differences in bone markers and bone mineral density of normal Chinese. Calcif Tissue Int 59:454–460

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank Dr. Daniel Steve Villarreal for English-language editing and Ms. Yu-Ting Hsu for help in picture editing. We also thank the patients who participated in this study. This study was supported in part by a grant from the Foundation for Medical Research of Tri-Service General Hospital (TSGH-C99-167).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Heng-Cheng Chu.

Additional information

The authors have stated that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lin, JC., Hsieh, TY., Wu, CC. et al. Association Between Chronic Hepatitis C Virus Infection and Bone Mineral Density. Calcif Tissue Int 91, 423–429 (2012). https://doi.org/10.1007/s00223-012-9653-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00223-012-9653-y

Keywords

Navigation